Diabetes, Obesity and Hyperlipidemias

Opening lecture. Cholesterol: 80 years since St. Petersburg (P. Avogaro). Morgagni lecture. Remnant lipoprotein metabolism (S. Eisenberg). Epidemiology of the plurimetabolic syndrome. The plurimetabolic syndrome and the study of men bom in 1913, Goteborg. Sweden (B. Larsson, L. Welin, H. Eriksson). The plurimetabolic syndrome and the Paris Prospective Study (B. Balkau, M.-A. Charles, A. Fonthonne, E. Eschwege. An epidemiologic view of the plurimetabolic syndrome: The Brisighella study (G.C. Descovich, B. Benassi, V. Cancelli, S. D'Addato, G. De Simone, A. Dormi on behalf of the Brisighella Study members). Pathogenesis of the plurimetabolic syndrome. The plurimetabolic syndrome in animals: Models for experimentation, their implications and relation to NIDDM (E. Shafrir). Regulation of glucose transporter and hexokinase gene expression during development (C. Postic, A. Leturque, R. Printz, D. Granner, J. Girard). Genetics of causes and manifestations of the metabolic syndrome (C. Bouchard, L. Perusse). Fate of glucose in insulin resistant states (H. Yki-Jarvinen). The possible pathophysiology of insulin resistance syndrome (M. La Alterations of intracellular glucose metabolism in the insulin-resistant states (S. Del Prato). The role of fat distribution in the development of the plurimetabolic syndrome (B. Bjorntorp). Muscle capillarisation and morphology and pathogenesis of metabolic syndrome (M. Krotkiewski). Microalbuminuria and the plurimetabolic syndrome. Towards understanding renal structure and function in type 2 diabetes mellitus (M.W. Steffes, P. Fioretto). Microalbuminuria, elevated blood pressure and the metabolic syndrome (C.E. Mogensen, E.M. Damsgaard, N.de Fine Olivarius, A. Froland, S. Nielsen, A. Schmitz, 0. Schmitz, E. Vestho). Albuminuria and cardiovascular disease in diabetes mellitus: The role of endothelial dysfuncfion (C.D.A. Stehouwer). Microalbuminuria as a tisk factor for cardiovascular disease in non-diabetic subjects (J.S. Yudkin). Abnormalities of cation transport systems in non-insulin-dependent diabetes mellitus (R.Trevisan, M.R Cipollina, E.Duner A.Solini. M. Trevisan, I. Barzon, R. Nosadini). Impaired peripheral glucose uptake in non - insulin dependent diabetic patients with hypertension and microalbuminuria ( A. Solini, M. Sambataro, E, Brocco, M.R. Cipollina, R .Nosadini, G.Crepaldi).Liquids and plurimetabolic syndrome. Insulin resistence and dyslipidemia ( I. Zzavaroni.) Lipid and lipoprotein anomalies in non-insulin dependent diabetes ( R.W. James, M. Boemi, P.Fumelli, D. Pometta). Associations between LDL subclass phenotypes and the risk factors of the insulin resistance syndrome (M.A. Austin, J.V. Selby). The lipoprotein metabolism in the plurimetabolic syndrome (A. Zambon, J.D. Brunzell). Familial association of dyslipidemia and hypertension (R.R. Williams, P.N. Hopkins, L.L. Wu, S.C. Hunt). Lipoproteins, hypertension, microalbuminuria and insulin resistance in type 2 diabetes (S. Zambon, A.